SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Wint raises $36 million Series D to use AI to detect water risks before they become costly damage

“It's less that nothing has ever gone wrong and more that the system is built to surface problems early”

Full list of Israeli startup M&As in 2026

Prytek acquires Scanovate for $50 million as it expands its financial infrastructure business

Buzz

Most popular

Daily

Weekly

1

What made Anthropic walk away from the $6 billion Decart deal?

2

Anthropic drops plans to acquire Israeli AI startup Decart

3

Palo Alto Networks founder Nir Zuk raises $245 million for new cybersecurity startup

4

Hapag-Lloyd and FIMI to submit improved bid for Zim

5

Israir sells $8 million of New York flights within hours of opening bookings

Second Quarter

2 stories about Second Quarter

מטה חברת טבע תרופות

Despite Losses, Teva Pays Employee Bonuses for 2018

13.08.19|Hezi Sternlicht

Though Teva ended 2018 with a net loss of over $2.45 billion, the company awarded its employees with bonuses worth $390 million for the fiscal year’s results

מנכ"ל טבע קאר שולץ קור שולץ קר שולץ מנכ"ל טבע פברואר 2018

Teva Beat Analysts’ Consensus, But Its Big Battles Are Still Up Ahead

08.08.19|Sophie Shulman

Teva ends the second quarter of 2019 down a CFO, with negative cash flow and the threat of lawsuits that could cost billions. In his call with analysts, CEO Kare Schultz hinted at the possibility of future layoffs, but Teva still handed out $240 million worth of annual bonuses to senior executives